Cargando…
Further evidence of clinical benefit associated with participation in phase I oncology trials
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275490/ https://www.ncbi.nlm.nih.gov/pubmed/18349816 http://dx.doi.org/10.1038/sj.bjc.6604206 |
| _version_ | 1782151873557430272 |
|---|---|
| author | Markman, M |
| author_facet | Markman, M |
| author_sort | Markman, M |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2275490 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2008 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-22754902009-09-10 Further evidence of clinical benefit associated with participation in phase I oncology trials Markman, M Br J Cancer Editorial Nature Publishing Group 2008-03-25 2008-03-18 /pmc/articles/PMC2275490/ /pubmed/18349816 http://dx.doi.org/10.1038/sj.bjc.6604206 Text en Copyright © 2008 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Editorial Markman, M Further evidence of clinical benefit associated with participation in phase I oncology trials |
| title | Further evidence of clinical benefit associated with participation in phase I oncology trials |
| title_full | Further evidence of clinical benefit associated with participation in phase I oncology trials |
| title_fullStr | Further evidence of clinical benefit associated with participation in phase I oncology trials |
| title_full_unstemmed | Further evidence of clinical benefit associated with participation in phase I oncology trials |
| title_short | Further evidence of clinical benefit associated with participation in phase I oncology trials |
| title_sort | further evidence of clinical benefit associated with participation in phase i oncology trials |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275490/ https://www.ncbi.nlm.nih.gov/pubmed/18349816 http://dx.doi.org/10.1038/sj.bjc.6604206 |
| work_keys_str_mv | AT markmanm furtherevidenceofclinicalbenefitassociatedwithparticipationinphaseioncologytrials |